These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10698445)

  • 21. Design, synthesis, and modeling of novel cyclic thrombin receptor-derived peptide analogues of the Ser42-Phe-Leu-Leu-Arg46 motif sequence with fixed conformations of pharmacophoric groups: importance of a Phe/Arg/NH2 cluster for receptor activation and implications in the design of nonpeptide thrombin receptor mimetics.
    Alexopoulos K; Panagiotopoulos D; Mavromoustakos T; Fatseas P; Paredes-Carbajal MC; Mascher D; Mihailescu S; Matsoukas J
    J Med Chem; 2001 Feb; 44(3):328-39. PubMed ID: 11462974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural analysis of thrombin complexed with potent inhibitors incorporating a phenyl group as a peptide mimetic and aminopyridines as guanidine substitutes.
    Bone R; Lu T; Illig CR; Soll RM; Spurlino JC
    J Med Chem; 1998 Jun; 41(12):2068-75. PubMed ID: 9622548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational design and selection of bivalent peptide ligands of thrombin incorporating P4-P1 tetrapeptide sequences: from good substrates to potent inhibitors.
    Su Z; Vinogradova A; Koutychenko A; Tolkatchev D; Ni F
    Protein Eng Des Sel; 2004 Aug; 17(8):647-57. PubMed ID: 15358856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
    Girnys EA; Sobczyk-Kojiro K; Mosberg HI
    Chem Biol Drug Des; 2010 Jan; 75(1):35-9. PubMed ID: 19954432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors.
    Tsuda Y; Cygler M; Gibbs BF; Pedyczak A; Féthière J; Yue SY; Konishi Y
    Biochemistry; 1994 Dec; 33(48):14443-51. PubMed ID: 7981204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the structures of the cyclotheonamide A complexes of human alpha-thrombin and bovine beta-trypsin.
    Ganesh V; Lee AY; Clardy J; Tulinsky A
    Protein Sci; 1996 May; 5(5):825-35. PubMed ID: 8732754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin.
    Wu TP; Yee V; Tulinsky A; Chrusciel RA; Nakanishi H; Shen R; Priebe C; Kahn M
    Protein Eng; 1993 Jul; 6(5):471-8. PubMed ID: 8415574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
    Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
    Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The solution conformation of (D)Phe-Pro-containing peptides: implications on the activity of Ac-(D)Phe-Pro-boroArg-OH, a potent thrombin inhibitor.
    Lim MS; Johnston ER; Kettner CA
    J Med Chem; 1993 Jun; 36(13):1831-8. PubMed ID: 8515421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small, low nanomolar, noncovalent thrombin inhibitors lacking a group to fill the 'distal binding pocket'.
    Sanderson PE; Cutrona KJ; Dyer DL; Krueger JA; Kuo LC; Lewis SD; Lucas BJ; Yan Y
    Bioorg Med Chem Lett; 2003 Jan; 13(2):161-4. PubMed ID: 12482415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design and characterization of D-Phe-Pro-D-Arg-derived direct thrombin inhibitors.
    Figueiredo AC; Clement CC; Zakia S; Gingold J; Philipp M; Pereira PJ
    PLoS One; 2012; 7(3):e34354. PubMed ID: 22457833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
    Priestle JP; Rahuel J; Rink H; Tones M; Grütter MG
    Protein Sci; 1993 Oct; 2(10):1630-42. PubMed ID: 8251938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic and crystallographic studies of thrombin with Ac-(D)Phe-Pro-boroArg-OH and its lysine, amidine, homolysine, and ornithine analogs.
    Weber PC; Lee SL; Lewandowski FA; Schadt MC; Chang CW; Kettner CA
    Biochemistry; 1995 Mar; 34(11):3750-7. PubMed ID: 7893672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
    Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
    Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
    Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS
    J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activities.
    Alexopoulos K; Fatseas P; Melissari E; Vlahakos D; Roumelioti P; Mavromoustakos T; Mihailescu S; Paredes-Carbajal MC; Mascher D; Matsoukas J
    J Med Chem; 2004 Jun; 47(13):3338-52. PubMed ID: 15189031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.
    Bode W; Mayr I; Baumann U; Huber R; Stone SR; Hofsteenge J
    EMBO J; 1989 Nov; 8(11):3467-75. PubMed ID: 2583108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New proline mimetics: synthesis of thrombin inhibitors incorporating cyclopentane- and cyclopentenedicarboxylic acid templates in the P2 position. Binding conformation investigated by X-ray crystallography.
    Nöteberg D; Brånalt J; Kvarnström I; Linschoten M; Musil D; Nyström JE; Zuccarello G; Samuelsson B
    J Med Chem; 2000 May; 43(9):1705-13. PubMed ID: 10794688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonpolar interactions of thrombin S' subsites with its bivalent inhibitor: methyl scan of the inhibitor linker.
    Slon-Usakiewicz JJ; Purisima E; Tsuda Y; Sulea T; Pedyczak A; Féthière J; Cygler M; Konishi Y
    Biochemistry; 1997 Nov; 36(44):13494-502. PubMed ID: 9354617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.